MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/17474930211057722

Медицинская библиотека · International journal of stroke : official journal of the International Stroke Society · 2022

Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.

Best Jonathan G, Arram Liz, Ahmed Norin, Balogun Maryam, Bennett Kate, Bordea Ekaterina, Campos Marta G, Caverly Emilia, Chau Marisa, Cohen Hannah, Dehbi Hakim-Moulay, Doré Caroline J, Engelter Stefan T, Fenner Robert, Freemantle Nick, Hunter Rachael, James Martin, Lip Gregory Yh, Murray Macey L, Norrving Bo, Sprigg Nikola, Veltkamp Roland, Zaczyk Iwona, Werring David J, OPTIMAS investigators

Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

RATIONALE: Atrial fibrillation causes one-fifth of ischemic strokes, with a high risk of early recurrence. Although long-term anticoagulation is highly effective for stroke prevention in atrial fibrillation, initiation after stroke is usually delayed by concerns over intracranial hemorrhage risk. Direct oral anticoagulants offer a significantly lower risk of intracranial hemorrhage than other anticoagulants, potentially allowing earlier anticoagulation and prevention of recurrence, but the safety and efficacy of this approach has not been established.

AIM: Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS) will investigate whether early treatment with a direct oral anticoagulant, within four days of stroke onset, is as effective or better than delayed initiation, 7 to 14 days from onset, in atrial fibrillation patients with acute ischemic stroke.

METHODS AND

DESIGN

OPTIMAS is a multicenter randomized controlled trial with blinded outcome adjudication. Participants with acute ischemic stroke and atrial fibrillation eligible for anticoagulation with a direct oral anticoagulant are randomized 1:1 to early or delayed initiation. As of December 2021, 88 centers in the United Kingdom have opened.

STUDY OUTCOMES: The primary outcome is a composite of recurrent stroke (ischemic stroke or symptomatic intracranial hemorrhage) and systemic arterial embolism within 90 days. Secondary outcomes include major bleeding, functional status, anticoagulant adherence, quality of life, health and social care resource use, and length of hospital stay.

SAMPLE SIZE TARGET: A total of 3478 participants assuming event rates of 11.5% in the control arm and 8% in the intervention arm, 90% power and 5% alpha. We will follow a non-inferiority gatekeeper analysis approach with a non-inferiority margin of 2 percentage points.

DISCUSSION: OPTIMAS aims to provide high-quality evidence on the safety and efficacy of early direct oral anticoagulant initiation after atrial fibrillation-associated ischemic stroke.Trial registrations: ISRCTN: 17896007; ClinicalTrials.gov: NCT03759938.

Для цитирования: Best Jonathan G, Arram Liz, Ahmed Norin, Balogun Maryam, Bennett Kate, Bordea Ekaterina, Campos Marta G, Caverly Emilia, Chau Marisa, Cohen Hannah, Dehbi Hakim-Moulay, Doré Caroline J, Engelter Stefan T, Fenner Robert, Freemantle Nick, Hunter Rachael, James Martin, Lip Gregory Yh, Murray Macey L, Norrving Bo, Sprigg Nikola, Veltkamp Roland, Zaczyk Iwona, Werring David J, OPTIMAS investigators. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.. International journal of stroke : official journal of the International Stroke Society. 2022. DOI: 10.1177/17474930211057722.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.